Giorgio Sesti

Pubblicazioni

Titolo Pubblicato in Anno
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis). data from randomized controlled trials DIABETES, OBESITY AND METABOLISM 2017
Duodenal sodium/glucose co-transporter 1 expression under fasting conditions is associated with postload hyperglycemia THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2017
Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals DIABETES RESEARCH AND CLINICAL PRACTICE 2017
Effects of glucagon-like peptide-1 receptor agonists on mortality and cardiovascular events. A comprehensive meta-analysis of randomized controlled trials INTERNATIONAL JOURNAL OF CARDIOLOGY 2017
Risk reclassification ability of uric acid for cardiovascular outcomes in essential hypertension INTERNATIONAL JOURNAL OF CARDIOLOGY 2017
Glucagon-like peptide-1 receptor agonists and atrial fibrillation. a systematic review and meta-analysis of randomised controlled trials JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2017
Predictors of response to glucagon-like peptide-1 receptor agonists. a meta-analysis and systematic review of randomized controlled trials ACTA DIABETOLOGICA 2017
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients ARCHIVES OF GERONTOLOGY AND GERIATRICS 2017
Defining aging phenotypes and related outcomes. clues to recognize frailty in hospitalized older patients THE JOURNALS OF GERONTOLOGY. SERIES A, BIOLOGICAL SCIENCES AND MEDICAL SCIENCES 2017
Comparative Impact of hypoglycemic agents on severity and extent of myocardial ischemia in patients with type 2 Diabetes mellitus undergoing myocardial perfusion scintigraphy JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 2016
Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2016
Cardiovascular outcome clinical trials in type 2 diabetes mellitus. what are the epidemiological and methodological evidence and the first evaluations to date? GIORNALE ITALIANO DI CARDIOLOGIA 2016
PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases EXPERT OPINION ON THERAPEUTIC TARGETS 2016
Additive effect of non-alcoholic fatty liver disease on metabolic syndrome-related endothelial dysfunction in hypertensive patients INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2016
The GLP-1 receptor agonists exenatide and liraglutide activate glucose transport by an AMPK-dependent mechanism JOURNAL OF TRANSLATIONAL MEDICINE 2016
Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice CARDIOVASCULAR DIABETOLOGY 2016
Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients ACTA DIABETOLOGICA 2016
A Phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes DIABETES CARE 2016
Multiplicative effect of serum phosphorus levels and insulin resistance on hypertensive vascular stiffness THROMBOSIS AND HAEMOSTASIS 2016
One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden ATHEROSCLEROSIS 2016

ERC

  • LS4_9
  • LS4_10

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

- Meccanismi molecolari dell’azione insulinica e della funzione pancreatica;

- Fisiopatologia del diabete tipo 2 e dell’obesità;

- Genetica dell’insulino-resistenza, del diabete tipo 2 e dell’obesità;

- Sindrome metabolica e prediabete;

- Obesità metabolicamente sana;

- Trattamento del diabete tipo 2;

- Ruolo dell’IGF-1 nella patologia cardiovascolare e metabolica;

- Infiammazione, disfunzione endoteliale e patologia cardiovascolare;

- Epatopatie croniche e danno cardio-metabolico

Keywords

Diabetes Mellitus
obesity
cardiovascular disease

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma